PTC Therapeutics Inc. sell Citigroup Inc.
Start price
27.10.23
/
50%
€17.60
Target price
27.10.24
€16.10
Performance (%)
72.73%
Price
26.07.24
€30.40
Summary
This prediction is currently active. The SELL prediction by Citigroup_Inc_ for PTC Therapeutics Inc. is trending in the completely wrong direction and now has a performance of 72.73%. This prediction currently runs until 27.10.24. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 0.662% | 0.662% |
iShares Core DAX® | 1.280% | 1.027% |
iShares Nasdaq 100 | -2.457% | -4.650% |
iShares Nikkei 225® | -2.006% | -2.091% |
iShares S&P 500 | -0.662% | -1.246% |
Comments by Citigroup_Inc_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $17.00 price target on the stock, down previously from $29.00.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.40
21.05.24
21.05.24
€23.95
21.05.25
21.05.25
-12.99%
26.07.24
26.07.24